US Bancorp’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.97K Sell
368
-47
-11% -$831 ﹤0.01% 3519
2025
Q4
$7.76K Buy
415
+47
+13% +$780 ﹤0.01% 3407
2025
Q3
$5.37K Buy
368
+9
+3% +$114 ﹤0.01% 3518
2025
Q2
$3.96K Sell
359
-146
-29% -$1.42K ﹤0.01% 3707
2025
Q1
$4.51K Buy
505
+146
+41% +$1.36K ﹤0.01% 3691
2024
Q4
$3.38K Buy
+359
New +$3.27K ﹤0.01% 3740
2024
Q3
Sell
-285
Closed -$2.42K 4179
2024
Q2
$2.42K Sell
285
-223
-44% -$2.01K ﹤0.01% 3682
2024
Q1
$4.56K Sell
508
-926
-65% -$8.58K ﹤0.01% 3549
2023
Q4
$16.1K Buy
1,434
+434
+43% +$4.37K ﹤0.01% 3139
2023
Q3
$8.63K Sell
1,000
-134
-12% -$1.29K ﹤0.01% 3227
2023
Q2
$11.7K Sell
1,134
-940
-45% -$10.4K ﹤0.01% 3204
2023
Q1
$22.5K Buy
2,074
+305
+17% +$3.23K ﹤0.01% 2930
2022
Q4
$19.8K Hold
1,769
﹤0.01% 2997
2022
Q3
$18K Sell
1,769
-779
-31% -$7.3K ﹤0.01% 3082
2022
Q2
$23K Sell
2,548
-29
-1% -$267 ﹤0.01% 2978
2022
Q1
$25K Buy
2,577
+4
+0.2% +$39 ﹤0.01% 2961
2021
Q4
$28K Buy
2,573
+2,424
+1,627% +$21.1K ﹤0.01% 2938
2021
Q3
$1K Buy
149
+109
+273% +$1.22K ﹤0.01% 4020
2021
Q2
$1K Hold
40
﹤0.01% 3945
2021
Q1
$1K Sell
40
-76
-66% -$1.44K ﹤0.01% 3829
2020
Q4
$2K Buy
+116
New +$2.08K ﹤0.01% 3606
2020
Q3
Sell
-188
Closed -$4K 3840
2020
Q2
$4K Buy
188
+113
+151% +$2.9K ﹤0.01% 3396
2020
Q1
$2K Hold
75
﹤0.01% 3494
2019
Q4
$2K Hold
75
﹤0.01% 3502
2019
Q3
$1K Buy
+75
New +$1.51K ﹤0.01% 3518
2016
Q1
Sell
-41
Closed -$1K 3649
2015
Q4
$1K Sell
41
-2,656
-98% -$42.1K ﹤0.01% 3536
2015
Q3
$29K Hold
2,697
﹤0.01% 2711
2015
Q2
$35K Sell
2,697
-3,344
-55% -$51.9K ﹤0.01% 2711
2015
Q1
$105K Buy
6,041
+41
+0.7% +$752 ﹤0.01% 2138
2014
Q4
$90K Buy
+6,000
New +$105K ﹤0.01% 2206
2014
Q3
Sell
-85
Closed -$2K 3567
2014
Q2
$2K Buy
+85
New +$2.56K ﹤0.01% 3384

Other funds holding TBPH